Amgen (AMGN) Price to Sales (2009 - 2026)

Amgen has reported Price to Sales for 18 years, with the latest figure at 19.47 in Q2 2026.

• On a quarterly basis, Price to Sales rose 18.91% year-over-year to 19.47 in Q2 2026; TTM through Jun 2026 was 5.14, a 19.38% increase from a year earlier, with the FY2025 full-year figure at 4.8, up 14.62% from the prior year.
• Price to Sales was 19.47 for Q2 2026 at Amgen, down from 22.03 in the prior quarter.
• The five-year high for Price to Sales was 305.56 in Q4 2022, with the low at 15.4 in Q4 2024.
• Average Price to Sales over 5 years is 35.02, with a median of 19.87 recorded in 2022.
• The sharpest annual moves came in 2022 and 2023: Price to Sales surged 1565.46% in 2022, then slumped 93.84% in 2023.
• Over 5 years, Price to Sales stood at 305.56 in 2022, then sank by 93.84% to 18.81 in 2023, then declined by 18.14% to 15.4 in 2024, then increased by 16.06% to 17.87 in 2025, then increased by 8.93% to 19.47 in 2026.
• The last three Price to Sales figures came in at 19.47 (Q2 2026), 22.03 (Q1 2026), and 17.87 (Q4 2025), per Business Quant data.